Coronavirus News LIVE Updates: In recent findings of the INSACOG genomic sequence study, the Delta (B.1.617.2) variant, which was responsible for the second Covid-19 wave has become the dominant variant in India. It has 50% higher transmission rate than Alpha (B.1.17) and the risk of breakthrough infections post Covid-19 vaccination is also high.
In the past 24 hours, India recorded 1.32 lakh fresh cases while the active caseload further declined to 16,35,993, as per the Health Ministry data. Calling for the imposition of a fine on China for global deaths and destruction, former US President Trump said that he was right about ‘China Virus coming from Wuhan Lab’, as now everyone, including ‘enemy’, is accepting it.
“The correspondence between Dr Fauci and China speaks too loudly for anyone to ignore. China should pay USD 10 trillion to America, and the world, for the death and destruction they have caused!” Trump said.
READ | India Mulling Probe Into Origin Of Covid-19, Proposal At An Early Stage
India is contemplating a criminal investigation into the origins of the Sars-Cov-2 virus that causes Covid-19, top sources have told CNN-News18, a revelation that comes in the backdrop of a growing…
READ | As Oppn Tears into Punjab Over 'Vaccine Scam', Will Takebacks be Enough to Save the State's Covid Response?
The Vaccine ‘Scam’, as it has been labelled by the Opposition, blew up in the face of the Congress government in Punjab on Friday as Chief Minister Captain Amarinder Singh had to order the withdrawal…
Thanks to the efforts of @POTUS, @WhiteHouse, & @DrSJaishankar, this policy change will hopefully increase the supply of raw materials globally and to India; boosting our vaccine production capacity and strengthening our united fight against this pandemic. https://t.co/bHADBwiUnm
— Adar Poonawalla (@adarpoonawalla) June 4, 2021
Zydus May Apply for EUA in 2 Weeks | In two weeks Zydus is likely to submit an application for emergency use authorisation for its covid vaccine to DCGI. If Zydus supplies 5 crore vaccines then it will be used for children as well. sources said. "The Covaxin trials on children will be completed in 8 weeks," it further said.
READ | After Centre's Rap, Punjab Cancels Order To Supply Vaccines To Private Hospitals
Soon after the Centre pulled up the Capt Amarinder Singh-led Punjab government of selling Covaxin doses at over and above the prices they were procured from the Centre triggering allegations of…
READ | One Can Get Covid-19 After Taking Two Vaccine Shots. Here's Why There Is No Need To Worry
Cases of people getting Covid-19 after receiving their full vaccine dose are rare but not unheard of.
Village Achieves 100% Vaccination 45+ Age Group | Ilaiyankudi, a village in Karaikal district, has achieved 100 per cent vaccination of all those aged 45 and above, according to the District Collector Arjun Sharma. With this, the village in Tirunallar area of the district has become the first village in the Union Territory of Puducherry to achieve the distinction, he said.
WATCH |
WATCH LIVE📡
— #IndiaFightsCorona (@COVIDNewsByMIB) June 4, 2021
Media briefing by @MoHFW_INDIA on current #COVID19 situation in the country at National Media Centre, #NewDelhi#Unite2FightCorona #IndiaFightsCorona https://t.co/NQI1U2hYZi
Maha Caps Mucormycosis Treatment Prices at Pvt Hosps | Maharashtra govt caps cost of treatment for mucormycosis in private hospitals. "Rate of treatment for this disease in urban & rural areas cannot be higher than fixed rate. If found that extra charges have been levied then excess amount shall be reimbursed to patient," reads order.
READ | 'Invite WHO to US for Study of Virus Origins': China's Replies to Fauci's Lab Leak Emails
The United States should invite the World Health Organisation to their country to study virus origins and explain their more than 200 bio labs all over the world, including the Fort Detrick lab,…
Over 3,000 pages of emails were obtained by the Washington Post, Buzzfeed News and CNN through Freedom of Information Act (FOIA) requests, date from January to June 2020. The emails revealed about early days of the US Covid outbreak. Dr Fauci and his colleagues took notice, in the early days, of the theory that Covid-19 may have leaked from a laboratory in Wuhan, China.
The United States President Biden has announced Global Allocation Plan of 25 million vaccines which is the first tranche of total 80 million vaccines announced earlier.
“Distribution under 2 categories – via COVAX initiative & directly to neighbors & partner countries. India to figure in both categories and get vaccines as per allocation under COVAX & direct supply. First will be COVAX initiative wherein India is included. Second, via direct supply to neighbors and partner countries including India, Korea, Canada and Mexico,” said Indian Ambassador to the US, TS Sandhu.
Ministers have moved to tighten Britain’s borders as new data has suggested that the Delta coronavirus variant is stealthy and much more likely to cause serious illness.
Residents of New Delhi are allegedly booking slots of second dose of Covaxin in Meerut, Uttar Pradesh, which is about 98 km from the national capital. “People from Delhi and Haryana are booking slots in Meerut for 2nd dose of Covaxin due to its shortage there. Around 70% slots of Covaxin’s 2nd dose for 18-44 age group have been booked by people from Delhi. We’re discouraging them,” said the District Immunization Officer Praveen Gautam.
Meanwhile, with England’s reopening on 21 June, the government removed Portugal from the green list of countries and added seven more countries to the red list – moves that provoked fury within the travel industry and left many holidaymakers in limbo reported The Guardian. Portugal, including Madeira and the Azores, was the only mainstream tourist destination Britons could visit without having to quarantine.
America’s top infectious disease specialist Dr Anthony Fauci on Thursday said the US is eager to involve Indian investigators in global clinical trials to evaluate the safety and efficacy of COVID-19 therapeutics. The National Institute of Allergy and Infectious Diseases has a long history of collaboration with its counterpart agencies in India, Dr Fauci said during a conversation organised by the US-India Strategic and Partnership Forum.
Under the long-standing Indo-US vaccine action programme, we will continue to work with India on research related to SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) vaccines. We also are eager to involve Indian investigators in sites in global clinical trials to evaluate the safety and efficacy of various COVID-19 therapeutics, he said.
Read all the Latest News, Breaking News and Coronavirus News here